These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 19074282)

  • 21. The new field of neuroskeletal biology.
    Patel MS; Elefteriou F
    Calcif Tissue Int; 2007 May; 80(5):337-47. PubMed ID: 17440766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signaling through the M(3) muscarinic receptor favors bone mass accrual by decreasing sympathetic activity.
    Shi Y; Oury F; Yadav VK; Wess J; Liu XS; Guo XE; Murshed M; Karsenty G
    Cell Metab; 2010 Mar; 11(3):231-8. PubMed ID: 20197056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leptin regulates bone formation via the sympathetic nervous system.
    Takeda S; Elefteriou F; Levasseur R; Liu X; Zhao L; Parker KL; Armstrong D; Ducy P; Karsenty G
    Cell; 2002 Nov; 111(3):305-17. PubMed ID: 12419242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone remodeling: new aspects of a key process that controls skeletal maintenance and repair.
    Pogoda P; Priemel M; Rueger JM; Amling M
    Osteoporos Int; 2005 Mar; 16 Suppl 2():S18-24. PubMed ID: 15551056
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serotonin, two faces of a unique molecule in the regulation of bone mass].
    Oury F; Karsenty G
    Med Sci (Paris); 2010; 26(8-9):713-8. PubMed ID: 20819707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of leptin in regulating appetite, neuroendocrine function, and bone remodeling.
    Cohen MM
    Am J Med Genet A; 2006 Mar; 140(5):515-24. PubMed ID: 16463275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A unified model for the action of leptin on bone turnover.
    Gordeladze JO; Reseland JE
    J Cell Biochem; 2003 Mar; 88(4):706-12. PubMed ID: 12577304
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of glucose metabolism and the skeleton.
    Ng KW
    Clin Endocrinol (Oxf); 2011 Aug; 75(2):147-55. PubMed ID: 21623861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanical Vibration Mitigates the Decrease of Bone Quantity and Bone Quality of Leptin Receptor-Deficient Db/Db Mice by Promoting Bone Formation and Inhibiting Bone Resorption.
    Jing D; Luo E; Cai J; Tong S; Zhai M; Shen G; Wang X; Luo Z
    J Bone Miner Res; 2016 Sep; 31(9):1713-24. PubMed ID: 26990203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone: from a reservoir of minerals to a regulator of energy metabolism.
    Confavreux CB
    Kidney Int Suppl; 2011 Apr; 79(121):S14-9. PubMed ID: 21346725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuronal Control of Bone Remodeling.
    Corr A; Smith J; Baldock P
    Toxicol Pathol; 2017 Oct; 45(7):894-903. PubMed ID: 29113558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Leptin].
    Ikeda K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():82-4. PubMed ID: 15035101
    [No Abstract]   [Full Text] [Related]  

  • 33. Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo.
    Cornish J; Callon KE; Bava U; Lin C; Naot D; Hill BL; Grey AB; Broom N; Myers DE; Nicholson GC; Reid IR
    J Endocrinol; 2002 Nov; 175(2):405-15. PubMed ID: 12429038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular bases of the sympathetic regulation of bone mass.
    Takeda S; Karsenty G
    Bone; 2008 May; 42(5):837-40. PubMed ID: 18295563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leptin: cutting the fat off the bone.
    Cock TA; Auwerx J
    Lancet; 2003 Nov; 362(9395):1572-4. PubMed ID: 14615115
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of osteocalcin in the endocrine cross-talk between bone remodelling and energy metabolism.
    Ducy P
    Diabetologia; 2011 Jun; 54(6):1291-7. PubMed ID: 21503740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothalamic control of bone formation: distinct actions of leptin and y2 receptor pathways.
    Baldock PA; Sainsbury A; Allison S; Lin EJ; Couzens M; Boey D; Enriquez R; During M; Herzog H; Gardiner EM
    J Bone Miner Res; 2005 Oct; 20(10):1851-7. PubMed ID: 16160743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ghrelin and bone.
    Delhanty PJ; van der Eerden BC; van Leeuwen JP
    Biofactors; 2014; 40(1):41-8. PubMed ID: 23804549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skeletal phenotype of the leptin receptor-deficient db/db mouse.
    Williams GA; Callon KE; Watson M; Costa JL; Ding Y; Dickinson M; Wang Y; Naot D; Reid IR; Cornish J
    J Bone Miner Res; 2011 Aug; 26(8):1698-709. PubMed ID: 21328476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The endocrine role of the skeleton: background and clinical evidence.
    Schwetz V; Pieber T; Obermayer-Pietsch B
    Eur J Endocrinol; 2012 Jun; 166(6):959-67. PubMed ID: 22436399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.